The purpose of this report is to provide an evidence-based, best practice summary to optimize the quality, safety and efficacy, and availability of renal rehabilitation service, and to provide care for maximum patient prognosis, quality of life, and satisfaction.
Featured article: Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases
Featured article: Annual Dialysis Data Report 2016, JSDT Renal Data Registry
The annual survey of The Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4396 dialysis facilities at the end of 2016, among which 4336 facilities (98.6%) responded.
Featured article: A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
Cell-integrated and wearable artificial kidneys aim to create convenient and efficient systems of filtration and restore elements of immunoregulatory function.
The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama
The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama
The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD)
5-7 September 2019, Nagoya Congress Center
The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
23-24 November - 30 November 2019, Hiroshima International Conference Center
The 31st Annual Meeting of the Japan Society for Blood Purification Critical Care
2020, Kofu Memorial Day's Hotel
The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation
20-21 March 2021, Sendai International Center
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Overcoming Language Barriers
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Renal Replacement Therapy is the official publication of the following societies:
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
128 days from submission to acceptance
27 days from acceptance to publication
23 Altmetric mentions